Fiona Brinkman, 34
Biotechnology
Simon Fraser University
Pathogens often exploit our cells to thrive. Fiona Brinkman therefore hypothesizes that some of their genes are similar to human genes. By identifying such genes computationally, Brinkman is trying to understand how drugs could stop pathogens from storming the body’s fortress. Brinkman coordinates this interdisciplinary work through an online “pathogenomics” project she runs from Simon Fraser University in British Columbia. It uses a free program she developed called PhyloBlast to evaluate relationships between genes by comparing their sequences and the proteins they code for. Previously, Brinkman organized the first Internet-based effort to refine and annotate bacterial genome data, focusing on P. aeruginosa, a widely drug- resistant bacterium that causes fatal infections in cystic-fibrosis patients. The group gained critical insight into how the bacterium works, which had eluded researchers. “Once we have the parts list for how the bug is functioning,” Brinkman says, “we can figure out new approaches to drugs.” Her collaborative electronic approach is now being used by other genome researchers.
2002 TR35 Winners
Ewan Birney
Biotechnology
Stephen Boppart
Medicine
Fiona Brinkman
Biotechnology
Stephen Brossette
Medicine
Chris Burge
Biotechnology
Benjamin Cravatt
Biotechnology
Nathaniel David
Biotechnology
Jennifer Elisseeff
Medicine
Susan Hagness
Medicine
Derek Hansford
Materials
John Harrington
Medicine
Suzie Hwang Pun
Medicine
J. Joseph Kim
Medicine
Steven Laken
Medicine
Corinna E. Lathan
Medicine
Kelvin Lee
Medicine
Surya Mallapragada
Medicine
Sean J. Morrison
Medicine
Milan Mrksich
Materials
Stephen OConnor
Biotechnology
Alexander Olek
Biotechnology
Vijay Pande
Biotechnology
Stephen Quake
Materials
David Sabatini
Biotechnology
John Santini
Medicine
David Schaffer
Medicine
Kevin Shakesheff
Materials
Vivek Subramanian
Materials
Christoph Westphal
Biotechnology

